Bibliografia UJ CM

1/2
C. Fernandez de Larrea, R.A. Kyle, B.G.M. Durie, H. Ludwig, S. Usmani, D.H. Vesole, R. Hajek, J.F. San Miguel, O. Sezer, P. Sonneveld, S.K. Kumar, A. Mahindra, R. Comenzo, A. Palumbo, A. Mazumber, K.C. Anderson, P.G. Richardson, A.Z. Badros, J. Caers, M. Cavo, X. LeLeu, M.A. Dimopoulos, C.S. Chim, R. Schots, A. Noeul, D. Fantl, U.-H. Mellqvist, O. Landgren, A. Chanan-Khan, P. Moreau, R. Fonseca, G. Merlini, J.J. Lahuerta, J. Blade, R.Z. Orlowski, J.J. Shah, International Myeloma Working Group.
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Leukemia
2013 : Vol. 27, nr 4, s. 780-791, il., bibliogr. 92 poz.
p-ISSN: 0887-6924
AZ
POG
AIF
IF: 9.379
Streszczenie w PubMed:
2/2
S.K. Kumar, J.H. Lee, J.J. Lahuerta, G[areth] Morgan, P.G. Richardson, J. Crowley, J. Haessle, J. Feather, A. Hoering, P. Moreau, X. LeLeu, C. Hulin, S.K. Klein, P. Sonneveld, D. Siegel, J. Blade, H. Goldschmidt, S. Jagannath, J.S. Miguel, W. Orlowski, A. Palumbo, O. Sezer, S.V. Rajkumar, B.G.M. Durie, International Myeloma Working Group.
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.
Leukemia
2012 : Vol. 26, nr 1, s. 149-157, il., bibliogr. 31 poz.
p-ISSN: 0887-6924
AZ
ORG
AIF
IF: 9.379
Streszczenie w PubMed:
Wyświetl ponownie stosując format: